Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate

Radiopharmaceuticals based on 90Y are widely used in the treatment of malignant deseases. In order to meet the requirements for their future application, a 90Sr/90Y generator was developed and 90Y eluted from this locally produced generator was used for the radiolabelling of the DOTA-conjugated soma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear Technology and Radiation Protection 2012, Vol.27 (3), p.260-268
Hauptverfasser: Petrovic, Djordje, Nikolic, Nadezda, Stankovic, Dragana, Djokic, Divna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 268
container_issue 3
container_start_page 260
container_title Nuclear Technology and Radiation Protection
container_volume 27
creator Petrovic, Djordje
Nikolic, Nadezda
Stankovic, Dragana
Djokic, Divna
description Radiopharmaceuticals based on 90Y are widely used in the treatment of malignant deseases. In order to meet the requirements for their future application, a 90Sr/90Y generator was developed and 90Y eluted from this locally produced generator was used for the radiolabelling of the DOTA-conjugated somatostatin analog [DOTA0,Tyr3] octreotate and the preparation of [90Y-DOTA0,Tyr3] octreotate (90Y-DOTATATE) for peptide receptore radionuclide therapy. 90Sr/90Y generator was based on the electrochemical separation of 90Y from 90Sr in a two-cycle electrolysis procedure. Three electrode cells were used to perform both electrolyses. In both cycles, working electrodes were kept on constant potential. The pH of the solution was adjusted to 2.7 of the value before the electrolyses. The radionuclidic purity of the 90Y solution was analysed by ITLC and extraction paper chromatography. The labelling of peptide (100 mg DOTATATE) with 90YCl3 was performed at 95?C for 30 minutes. Radiochemical purity was determined by HPLC and chromatographic separation, using a solid SepPak C-18 column. Results obtained confirmed the efficiency of our electrochemical separation technique and quality control methods for 90Y. The achieved efficiency of the 90Sr/90Y generator above 96% of the theoretical value represents a good basis for the further development of this generator. The labelling of the DOTATATE with 90Y exhibited a high efficiency, too: there was less than 1% of 90Y3+in the 90Y-DOTATATE. Radiofarmaceutici bazirani na 90Y se sve vise koriste u tretmanu malignih oboljenja. Da bi se izislo u susret buducim potrebama, razvijen je 90Sr/90Y generator. Dobiveni 90Y eluat je koriscen za radioobelezavanje analoga konjugovanog DOTA somatostatina [DOTA0, Tyr3] octreotate i pripremanje [90Y-DOTA0, Tyr3] octreotate (90Y-DOTATATE), peptidnim receptorima u radionuklidnoj terapiji. 90Sr/90Y generator je baziran na elektrohemijskom odvajanju 90Y od 90Sr u dvostepenoj elektrolizi. Sistem sa tri elektrode je koriscen za obe elektrolize. U svakoj elektrolizi potencijal radne elektrode je odrzavan konstantnim, dok je pH vrednost rastvora bila podesena na 2,7. Radionuklidna cistoca rastvora 90Y je analizirana pomocu instant tankoslojne i papirne hromatografije. Peptid (100 mg DOTATATE) je obelezavan 30 minuta na 95?C. Radiohemijska cistoca je odredjena pomocu HPLC i hromatografskim razdvajanjem koristeci cvrstu SepPak C-18 kolonu. Dobiveni rezultati potvrdjuju efikasnost kako elektrohemijskog odvajan
doi_str_mv 10.2298/NTRP1203260P
format Article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2298_NTRP1203260P</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_32ac7d980d2d4621859753f820e6aa7a</doaj_id><sourcerecordid>oai_doaj_org_article_32ac7d980d2d4621859753f820e6aa7a</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184p-5e4b7c35c69048050a0756c7a7cc4a74b497f82a0a3a846c6cf9e487280d05063</originalsourceid><addsrcrecordid>eNpdkdtO3DAQhqOKShzaOx7AD0DKxHZ8uESUFiRUULu9qCoUzTqT4FU2Xtnei32sviFeQBXiag76_--XZqrqtIEvnFtz_mPx877hILiC-w_VUSNbXpvGtAfPfVMLa-VhdZzSCkBq1aqj6t_VRC7H4B5p7R1OLNEGI2YfZhYGZqHe5Rz9ds38zPIjMXqnt_Arnlv4w0aaqRhDZDj3zOfEtonYUOaIvQ8TLmma_DzusV_vFhe1C_NqO2KmnqWwLs6US-5c7DiFkf3di-CMLXZRPLBQQikUAX2qPg44Jfr8Wk-q39-uFpfX9e3d95vLi9vaNUZu6pbkUjvROmVBGmgBQbfKadTOSdRyKa0eDEdAgUYqp9xgSRrNDfRFrcRJdfPC7QOuuk30a4y7LqDvnhchjh3G7N1EneDodG-Lk_dS8XJxq1tR6EAKUWNhnb2wXAwpRRr-8xro9q_r3r5OPAFs_I1C</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Petrovic, Djordje ; Nikolic, Nadezda ; Stankovic, Dragana ; Djokic, Divna</creator><creatorcontrib>Petrovic, Djordje ; Nikolic, Nadezda ; Stankovic, Dragana ; Djokic, Divna</creatorcontrib><description>Radiopharmaceuticals based on 90Y are widely used in the treatment of malignant deseases. In order to meet the requirements for their future application, a 90Sr/90Y generator was developed and 90Y eluted from this locally produced generator was used for the radiolabelling of the DOTA-conjugated somatostatin analog [DOTA0,Tyr3] octreotate and the preparation of [90Y-DOTA0,Tyr3] octreotate (90Y-DOTATATE) for peptide receptore radionuclide therapy. 90Sr/90Y generator was based on the electrochemical separation of 90Y from 90Sr in a two-cycle electrolysis procedure. Three electrode cells were used to perform both electrolyses. In both cycles, working electrodes were kept on constant potential. The pH of the solution was adjusted to 2.7 of the value before the electrolyses. The radionuclidic purity of the 90Y solution was analysed by ITLC and extraction paper chromatography. The labelling of peptide (100 mg DOTATATE) with 90YCl3 was performed at 95?C for 30 minutes. Radiochemical purity was determined by HPLC and chromatographic separation, using a solid SepPak C-18 column. Results obtained confirmed the efficiency of our electrochemical separation technique and quality control methods for 90Y. The achieved efficiency of the 90Sr/90Y generator above 96% of the theoretical value represents a good basis for the further development of this generator. The labelling of the DOTATATE with 90Y exhibited a high efficiency, too: there was less than 1% of 90Y3+in the 90Y-DOTATATE. Radiofarmaceutici bazirani na 90Y se sve vise koriste u tretmanu malignih oboljenja. Da bi se izislo u susret buducim potrebama, razvijen je 90Sr/90Y generator. Dobiveni 90Y eluat je koriscen za radioobelezavanje analoga konjugovanog DOTA somatostatina [DOTA0, Tyr3] octreotate i pripremanje [90Y-DOTA0, Tyr3] octreotate (90Y-DOTATATE), peptidnim receptorima u radionuklidnoj terapiji. 90Sr/90Y generator je baziran na elektrohemijskom odvajanju 90Y od 90Sr u dvostepenoj elektrolizi. Sistem sa tri elektrode je koriscen za obe elektrolize. U svakoj elektrolizi potencijal radne elektrode je odrzavan konstantnim, dok je pH vrednost rastvora bila podesena na 2,7. Radionuklidna cistoca rastvora 90Y je analizirana pomocu instant tankoslojne i papirne hromatografije. Peptid (100 mg DOTATATE) je obelezavan 30 minuta na 95?C. Radiohemijska cistoca je odredjena pomocu HPLC i hromatografskim razdvajanjem koristeci cvrstu SepPak C-18 kolonu. Dobiveni rezultati potvrdjuju efikasnost kako elektrohemijskog odvajanja, tako i metodu za kontrolu kvaliteta 90Y. Postignuta efikasnost 90Sr/90Y generatora od 96% teorijske vrednosti je dobra osnova za buduci razvoj ovog generatora. Obelezavanje DOTATATE sa 90Y je takodje bilo visoko efikasno jer je bilo manje od 1% slobodnog Y3+ u rastvoru nakon obelezavanja 90Y-DOTATATE. PR Projekat Ministarstva nauke Republike Srbije, br. 45015</description><identifier>ISSN: 1451-3994</identifier><identifier>EISSN: 1452-8185</identifier><identifier>DOI: 10.2298/NTRP1203260P</identifier><language>eng</language><publisher>VINCA Institute of Nuclear Sciences</publisher><subject>90Sr/90Y generator ; 90Y ; 90Y-DOTATATE ; radiolabelling ; radionuclide therapy</subject><ispartof>Nuclear Technology and Radiation Protection, 2012, Vol.27 (3), p.260-268</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c184p-5e4b7c35c69048050a0756c7a7cc4a74b497f82a0a3a846c6cf9e487280d05063</citedby><orcidid>0000-0002-1083-0265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Petrovic, Djordje</creatorcontrib><creatorcontrib>Nikolic, Nadezda</creatorcontrib><creatorcontrib>Stankovic, Dragana</creatorcontrib><creatorcontrib>Djokic, Divna</creatorcontrib><title>Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate</title><title>Nuclear Technology and Radiation Protection</title><description>Radiopharmaceuticals based on 90Y are widely used in the treatment of malignant deseases. In order to meet the requirements for their future application, a 90Sr/90Y generator was developed and 90Y eluted from this locally produced generator was used for the radiolabelling of the DOTA-conjugated somatostatin analog [DOTA0,Tyr3] octreotate and the preparation of [90Y-DOTA0,Tyr3] octreotate (90Y-DOTATATE) for peptide receptore radionuclide therapy. 90Sr/90Y generator was based on the electrochemical separation of 90Y from 90Sr in a two-cycle electrolysis procedure. Three electrode cells were used to perform both electrolyses. In both cycles, working electrodes were kept on constant potential. The pH of the solution was adjusted to 2.7 of the value before the electrolyses. The radionuclidic purity of the 90Y solution was analysed by ITLC and extraction paper chromatography. The labelling of peptide (100 mg DOTATATE) with 90YCl3 was performed at 95?C for 30 minutes. Radiochemical purity was determined by HPLC and chromatographic separation, using a solid SepPak C-18 column. Results obtained confirmed the efficiency of our electrochemical separation technique and quality control methods for 90Y. The achieved efficiency of the 90Sr/90Y generator above 96% of the theoretical value represents a good basis for the further development of this generator. The labelling of the DOTATATE with 90Y exhibited a high efficiency, too: there was less than 1% of 90Y3+in the 90Y-DOTATATE. Radiofarmaceutici bazirani na 90Y se sve vise koriste u tretmanu malignih oboljenja. Da bi se izislo u susret buducim potrebama, razvijen je 90Sr/90Y generator. Dobiveni 90Y eluat je koriscen za radioobelezavanje analoga konjugovanog DOTA somatostatina [DOTA0, Tyr3] octreotate i pripremanje [90Y-DOTA0, Tyr3] octreotate (90Y-DOTATATE), peptidnim receptorima u radionuklidnoj terapiji. 90Sr/90Y generator je baziran na elektrohemijskom odvajanju 90Y od 90Sr u dvostepenoj elektrolizi. Sistem sa tri elektrode je koriscen za obe elektrolize. U svakoj elektrolizi potencijal radne elektrode je odrzavan konstantnim, dok je pH vrednost rastvora bila podesena na 2,7. Radionuklidna cistoca rastvora 90Y je analizirana pomocu instant tankoslojne i papirne hromatografije. Peptid (100 mg DOTATATE) je obelezavan 30 minuta na 95?C. Radiohemijska cistoca je odredjena pomocu HPLC i hromatografskim razdvajanjem koristeci cvrstu SepPak C-18 kolonu. Dobiveni rezultati potvrdjuju efikasnost kako elektrohemijskog odvajanja, tako i metodu za kontrolu kvaliteta 90Y. Postignuta efikasnost 90Sr/90Y generatora od 96% teorijske vrednosti je dobra osnova za buduci razvoj ovog generatora. Obelezavanje DOTATATE sa 90Y je takodje bilo visoko efikasno jer je bilo manje od 1% slobodnog Y3+ u rastvoru nakon obelezavanja 90Y-DOTATATE. PR Projekat Ministarstva nauke Republike Srbije, br. 45015</description><subject>90Sr/90Y generator</subject><subject>90Y</subject><subject>90Y-DOTATATE</subject><subject>radiolabelling</subject><subject>radionuclide therapy</subject><issn>1451-3994</issn><issn>1452-8185</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdkdtO3DAQhqOKShzaOx7AD0DKxHZ8uESUFiRUULu9qCoUzTqT4FU2Xtnei32sviFeQBXiag76_--XZqrqtIEvnFtz_mPx877hILiC-w_VUSNbXpvGtAfPfVMLa-VhdZzSCkBq1aqj6t_VRC7H4B5p7R1OLNEGI2YfZhYGZqHe5Rz9ds38zPIjMXqnt_Arnlv4w0aaqRhDZDj3zOfEtonYUOaIvQ8TLmma_DzusV_vFhe1C_NqO2KmnqWwLs6US-5c7DiFkf3di-CMLXZRPLBQQikUAX2qPg44Jfr8Wk-q39-uFpfX9e3d95vLi9vaNUZu6pbkUjvROmVBGmgBQbfKadTOSdRyKa0eDEdAgUYqp9xgSRrNDfRFrcRJdfPC7QOuuk30a4y7LqDvnhchjh3G7N1EneDodG-Lk_dS8XJxq1tR6EAKUWNhnb2wXAwpRRr-8xro9q_r3r5OPAFs_I1C</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Petrovic, Djordje</creator><creator>Nikolic, Nadezda</creator><creator>Stankovic, Dragana</creator><creator>Djokic, Divna</creator><general>VINCA Institute of Nuclear Sciences</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1083-0265</orcidid></search><sort><creationdate>2012</creationdate><title>Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate</title><author>Petrovic, Djordje ; Nikolic, Nadezda ; Stankovic, Dragana ; Djokic, Divna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184p-5e4b7c35c69048050a0756c7a7cc4a74b497f82a0a3a846c6cf9e487280d05063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>90Sr/90Y generator</topic><topic>90Y</topic><topic>90Y-DOTATATE</topic><topic>radiolabelling</topic><topic>radionuclide therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Petrovic, Djordje</creatorcontrib><creatorcontrib>Nikolic, Nadezda</creatorcontrib><creatorcontrib>Stankovic, Dragana</creatorcontrib><creatorcontrib>Djokic, Divna</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nuclear Technology and Radiation Protection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petrovic, Djordje</au><au>Nikolic, Nadezda</au><au>Stankovic, Dragana</au><au>Djokic, Divna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate</atitle><jtitle>Nuclear Technology and Radiation Protection</jtitle><date>2012</date><risdate>2012</risdate><volume>27</volume><issue>3</issue><spage>260</spage><epage>268</epage><pages>260-268</pages><issn>1451-3994</issn><eissn>1452-8185</eissn><abstract>Radiopharmaceuticals based on 90Y are widely used in the treatment of malignant deseases. In order to meet the requirements for their future application, a 90Sr/90Y generator was developed and 90Y eluted from this locally produced generator was used for the radiolabelling of the DOTA-conjugated somatostatin analog [DOTA0,Tyr3] octreotate and the preparation of [90Y-DOTA0,Tyr3] octreotate (90Y-DOTATATE) for peptide receptore radionuclide therapy. 90Sr/90Y generator was based on the electrochemical separation of 90Y from 90Sr in a two-cycle electrolysis procedure. Three electrode cells were used to perform both electrolyses. In both cycles, working electrodes were kept on constant potential. The pH of the solution was adjusted to 2.7 of the value before the electrolyses. The radionuclidic purity of the 90Y solution was analysed by ITLC and extraction paper chromatography. The labelling of peptide (100 mg DOTATATE) with 90YCl3 was performed at 95?C for 30 minutes. Radiochemical purity was determined by HPLC and chromatographic separation, using a solid SepPak C-18 column. Results obtained confirmed the efficiency of our electrochemical separation technique and quality control methods for 90Y. The achieved efficiency of the 90Sr/90Y generator above 96% of the theoretical value represents a good basis for the further development of this generator. The labelling of the DOTATATE with 90Y exhibited a high efficiency, too: there was less than 1% of 90Y3+in the 90Y-DOTATATE. Radiofarmaceutici bazirani na 90Y se sve vise koriste u tretmanu malignih oboljenja. Da bi se izislo u susret buducim potrebama, razvijen je 90Sr/90Y generator. Dobiveni 90Y eluat je koriscen za radioobelezavanje analoga konjugovanog DOTA somatostatina [DOTA0, Tyr3] octreotate i pripremanje [90Y-DOTA0, Tyr3] octreotate (90Y-DOTATATE), peptidnim receptorima u radionuklidnoj terapiji. 90Sr/90Y generator je baziran na elektrohemijskom odvajanju 90Y od 90Sr u dvostepenoj elektrolizi. Sistem sa tri elektrode je koriscen za obe elektrolize. U svakoj elektrolizi potencijal radne elektrode je odrzavan konstantnim, dok je pH vrednost rastvora bila podesena na 2,7. Radionuklidna cistoca rastvora 90Y je analizirana pomocu instant tankoslojne i papirne hromatografije. Peptid (100 mg DOTATATE) je obelezavan 30 minuta na 95?C. Radiohemijska cistoca je odredjena pomocu HPLC i hromatografskim razdvajanjem koristeci cvrstu SepPak C-18 kolonu. Dobiveni rezultati potvrdjuju efikasnost kako elektrohemijskog odvajanja, tako i metodu za kontrolu kvaliteta 90Y. Postignuta efikasnost 90Sr/90Y generatora od 96% teorijske vrednosti je dobra osnova za buduci razvoj ovog generatora. Obelezavanje DOTATATE sa 90Y je takodje bilo visoko efikasno jer je bilo manje od 1% slobodnog Y3+ u rastvoru nakon obelezavanja 90Y-DOTATATE. PR Projekat Ministarstva nauke Republike Srbije, br. 45015</abstract><pub>VINCA Institute of Nuclear Sciences</pub><doi>10.2298/NTRP1203260P</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1083-0265</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1451-3994
ispartof Nuclear Technology and Radiation Protection, 2012, Vol.27 (3), p.260-268
issn 1451-3994
1452-8185
language eng
recordid cdi_crossref_primary_10_2298_NTRP1203260P
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects 90Sr/90Y generator
90Y
90Y-DOTATATE
radiolabelling
radionuclide therapy
title Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T21%3A48%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrochemical%20separation%20of%2090-yttrium%20in%20the%20electrochemical%2090Sr/90Y%20generator%20and%20its%20use%20for%20radiolabelling%20of%20DOTA-conjugated%20somatostatin%20analog%20%5BDOTA0,%20Tyr3%5D%20octreotate&rft.jtitle=Nuclear%20Technology%20and%20Radiation%20Protection&rft.au=Petrovic,%20Djordje&rft.date=2012&rft.volume=27&rft.issue=3&rft.spage=260&rft.epage=268&rft.pages=260-268&rft.issn=1451-3994&rft.eissn=1452-8185&rft_id=info:doi/10.2298/NTRP1203260P&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_32ac7d980d2d4621859753f820e6aa7a%3C/doaj_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_doaj_id=oai_doaj_org_article_32ac7d980d2d4621859753f820e6aa7a&rfr_iscdi=true